Genetic testing lowers risk of nevirapine skin rash
Kidney problems linked to tenofovir use, improve with switch to abacavir
Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children
Studies look at bone changes during second-line therapy, fractures, and HIV- and HCV-related bone loss
Long-acting GSK1265744 and TMC278-LA appear safe and practical in early study
No increase in risk behaviour in people taking antiretroviral therapy, meta-analysis shows
First-line antiretroviral therapy has improved over time, meta-analysis shows
